Kara L. Mungovan
Lawyers
Filters
Sirio Pharma acquisition of a majority stake of Best Formulations
We advised Sirio Pharma on the acquisition
Save A Lot $415 million term loan and $200 million ABL facilities refinancing
We advised Moran Foods on the refinancing
Chart Industries $1.97 billion notes offering
The high-yield senior notes are due 2030 and 2031
Chart Industries $1.1 billion common and depositary share offerings
The proceeds will be used to fund in part the acquisition of Howden
Telefónica Celular del Paraguay cash tender offer
We advised TELECEL on its tender offer for its outstanding 5.875% senior notes due 2027
RAPT Therapeutics $75 million follow-on offering
The shares are listed on the Nasdaq Global Market
Privia Health $135 million secondary offering
We advised Privia on its debut shelf takedown offering
KOITO $100 million investment in Cepton
We are advising KOITO on its investment in convertible preferred stock
One Manhattan Square $217 million mortgage loan
We advised Extell on the refinancing
Roivant Sciences $150 million equity offering
We advised the company on its debut SEC-registered primary and secondary offering